Dell Technologies Inc. (NYSE: DELL): What EMC’s $984.3 m Air Force award means for defense IT strategy
Read More Pharma Industry News Biotech rivals clash as Arrowhead sues Ionis over RNA-based triglyceride therapy Arrowhead sues Ionis over APOC3 patent dispute as plozasiran nears FDA approval. Discover what’s at stake in this RNA-based biotech rivalry. byPallavi MadhirajuSeptember 11, 2025